Pulmonary Disease, Chronic Obstructive Clinical Trial
Official title:
Registry of COPD Patients Who Undergo Outpatient Treatment or Are Under Surveillance at Outpatient Polyclinic Healthcare Institutions of the Russian Federation in Moscow
To describe the clinical profile of COPD patient who is under outpatient surveillance at polyclinic institutions of Moscow (including demographic data (age, gender, ethnicity, occupation), smoking status, disease duration, disease severity grade, distribution by disease phenotype, disease exacerbation rate in the setting of real-life clinical practice).
The registry of COPD patients in fact represents non-interventional multicenter retrospective
study including all COPD patients included into the registry retrospectively from patients
medical records and newly diagnosed under outpatient surveillance at the selected polyclinic
institutions of Moscow.
The registry will include all patients with registered diagnoses J40 - J44 according to
ICD-10 with spirometry results confirming COPD diagnosis, who are at the study start under
outpatient surveillance, and also newly registered patients diagnosed with COPD (ICD-10 J40 -
J44, as confirmed by spirometry results) during the conduction of the registry program at the
selected polyclinic institutions of Moscow (according to ICD: J40 - Bronchitis, not specified
as acute or chronic, J41 - Simple and mucopurulent chronic bronchitis, J41.0 - Simple chronic
bronchitis, J41.8 - Mixed simple and mucopurulent chronic bronchitis, J 42 - Unspecified
chronic bronchitis, J 43 - Emphysema, J 44 - Other chronic obstructive pulmonary disease)
based on regular (yearly) retrospective analysis of patient records with data entry into a
consolidated database.
It is planned to enrol into the study approximately 2000 male and female patients over 40
years of age with diagnosed COPD (as confirmed by spirometry results).
The present observational multicenter descriptive study will be conducted in the setting of
routine clinical practice of outpatient polyclinic institutions. There is no hypothesis to be
tested in this study.
The study will be conducted in outpatient polyclinic institutions of the primary medical care
system of Moscow. Pulmonologists of the primary medical care system will be engaged as
investigators. These are the physicians, whom the patients with tentative COPD diagnosis are
referred to in the Russian Federation and who within the scope of their responsibilities have
access to source medical records and who evaluate the quality of diagnosis and extent of
treatment prescribed to COPD patients.
The present study is observational therefore it does not require a treatment regimen or
directions for patient management. The patients receive medical care in line with routine
practice for treatment of this disease in the Russian Federation. Patient participation in
the study should not in any way affect the principles and extent of treatment received by the
patient according to routine clinical practice.
Physicians-investigators will enter into the study the information (data) concerning COPD
patients, both those already registered at the selected medical treatment and preventive care
institution, and newly registered patients as they seek attention at the outpatient
polyclinic institutions.
The main purpose of the present study consists in collection of data concerning COPD patients
who under surveillance at outpatient polyclinic institutions of Moscow using patient medical
records and their medical history. This protocol does not specify any obligatory visits or
examinations.
Patient data will be entered into the registry de-identified. The patients will be identified
by their screening number and initials. Then the Physician-investigator will evaluate patient
compliance with inclusion criteria. The study will enrol patients meeting all the inclusion
criteria and not having any of the exclusion criteria.
Only the physician who enters patient data into the regional COPD registry possesses patient
contact information, and henceforth only this physician will enter de-identified patient data
according to study design. This physician does not influence the choice of examination
extent, treatment strategy and medication.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
| Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
| Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
| Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
| Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
| Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
| Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
| Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
| Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
| Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
| Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
| Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
| Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
| Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
| Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
| Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
| Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
| Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|